BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15300196)

  • 1. RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells.
    Torquati A; O'rear L; Longobardi L; Spagnoli A; Richards WO; Daniel Beauchamp R
    Surgery; 2004 Aug; 136(2):310-6. PubMed ID: 15300196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
    Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
    Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
    Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
    Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling.
    Saeki N; Kim DH; Usui T; Aoyagi K; Tatsuta T; Aoki K; Yanagihara K; Tamura M; Mizushima H; Sakamoto H; Ogawa K; Ohki M; Shiroishi T; Yoshida T; Sasaki H
    Oncogene; 2007 Oct; 26(45):6488-98. PubMed ID: 17471240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.
    Mabuchi M; Kataoka H; Miura Y; Kim TS; Kawaguchi M; Ebi M; Tanaka M; Mori Y; Kubota E; Mizushima T; Shimura T; Mizoshita T; Tanida S; Kamiya T; Asai K; Joh T
    Biochem Biophys Res Commun; 2010 Jul; 398(2):321-5. PubMed ID: 20599712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
    Halder SK; Beauchamp RD; Datta PK
    Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells.
    Mithani SK; Balch GC; Shiou SR; Whitehead RH; Datta PK; Beauchamp RD
    J Surg Res; 2004 Apr; 117(2):296-305. PubMed ID: 15047135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma.
    Hughes SJ; Nambu Y; Soldes OS; Hamstra D; Rehemtulla A; Iannettoni MD; Orringer MB; Beer DG
    Cancer Res; 1997 Dec; 57(24):5571-8. PubMed ID: 9407969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
    Lee CW; Ito K; Ito Y
    Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line.
    He WX; Niu ZY; Zhao SL; Smith AJ
    Arch Oral Biol; 2005 Nov; 50(11):929-36. PubMed ID: 16183370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide YY inhibits the growth of Barrett's esophageal adenocarcinoma in vitro.
    McFadden DW; Riggs DR; Jackson BJ; Vona-Davis L
    Am J Surg; 2004 Nov; 188(5):516-9. PubMed ID: 15546561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
    O'Rear L; Longobardi L; Torello M; Law BK; Moses HL; Chiarelli F; Spagnoli A
    J Mol Endocrinol; 2005 Jun; 34(3):723-37. PubMed ID: 15956343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis.
    Sakakura C; Miyagawa K; Fukuda KI; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ida H; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Ito K; Hagiwara A; Ito Y
    Oncogene; 2007 Aug; 26(40):5927-38. PubMed ID: 17384682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
    Edmiston JS; Yeudall WA; Chung TD; Lebman DA
    Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth regulation of gastric epithelial cells by Runx3.
    Fukamachi H; Ito K
    Oncogene; 2004 May; 23(24):4330-5. PubMed ID: 15156189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic pathway induced by transduction of RUNX3 in the human gastric carcinoma cell line MKN-1.
    Nagahama Y; Ishimaru M; Osaki M; Inoue T; Maeda A; Nakada C; Moriyama M; Sato K; Oshimura M; Ito H
    Cancer Sci; 2008 Jan; 99(1):23-30. PubMed ID: 17956589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
    Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S
    Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta 1-induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-acetylcysteine and bcl-2.
    Lafon C; Mathieu C; Guerrin M; Pierre O; Vidal S; Valette A
    Cell Growth Differ; 1996 Aug; 7(8):1095-104. PubMed ID: 8853906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.